MedTrace Logo

Effect of Chronic PDE5-Inhibition on Endothelial Function in Diabetics

NCT00420901 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2007-01-11

No results posted yet for this study

Summary

chronic PDE5-Inhibition improves endothelial function in diabetics

Conditions

Interventions

DRUG

sildenafil

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • giuseppe rosano, md · San Raffaele EUR

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Completion
2000-02-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420901 on ClinicalTrials.gov